Alimta approved for nonsquamous non-small cell lung cancer (NSCLC) maintenance therapy - MPR
Links shared publicly online about this topic.
- 1,917total visits
Alimta approved for nonsquamous non-small cell lung cancer (NSCLC) maintenance therapy - MPR
empr.com —
View full resource at empr.com
Tags: Lung Cancer, Non-Small Cell Lung Cancer, Non-Small Cell Lung Cancer Medication, Lung, Disease and Condition, FDA, Alimta, Eli Lilly and Company
Most Recently Shared on July 6, 2009 at 3:50 pm By:
MPR News: Alimta approved for nonsquamous non-small cell lung cancer (NSCLC) maintenance therapy: The F.. http://tinyurl.com/mvpd5u
EC approves Lilly's ALIMTA as continuation maintenance therapy for NSCLC
news-medical.net — “Eli Lilly and Company announced today that the European Commission has granted approval for the use of ALIMTA (pemetrexed for injection) as a single agent for continuation maintenance therapy in patients with a particular type of lung cancer, called advanced nonsquamous non-small cell lung cancer” View full resource at news-medical.net
Most Recently Shared on October 29, 2011 at 5:56 am By:
Lung Cancer News: EC approves Lilly's ALIMTA as continuation maintenance therapy for NSCLC: Eli Lilly and Compan... http://t.co/xBsLdjbe
Study reveals that patients with NSCLC who received maintenance therapy with ALIMTA showed survival benefit
news-medical.net — “Data published today in The Lancet showed a survival benefit in nonsquamous patients with advanced non-small cell lung cancer (NSCLC) who received maintenance therapy with ALIMTA(R) (pemetrexed for injection) plus best supportive care as compared to placebo plus best supportive care.” View full resource at news-medical.net
Most Recently Shared on September 21, 2009 at 7:10 pm By:
Lung Cancer News: Study reveals that patients with NSCLC who received maintenance therapy with .. http://digg.com/u1Cs3O
Eli Lilly and Company - ALIMTA(R) (pemetrexed for injection) First Agent Approved in Europe as Maintenance Therapy for Advanced, Nonsquamous Non-Small Cell Lung Cancer
newsroom.lilly.com — “Eli Lilly and Company - ALIMTA(R) (pemetrexed for injection) First Agent Approved in Europe as Maintenance Therapy for Advanced, Nonsquamous Non-Small Cell Lung Cancer” View full resource at newsroom.lilly.com
Most Recently Shared on July 10, 2009 at 5:45 pm By:
eyeonfda Pharma and Health Lawyer
ALIMTA(R) (pemetrexed for injection) 1st Approval in EUas Maintenance Therapy for Adv Nonsquamous NSC Lung Cancer http://bit.ly/rwSmS
Eli Lilly and Company - Lilly Receives Fourth FDA Approval for ALIMTA(R) (pemetrexed for injection)
newsroom.lilly.com — “Eli Lilly and Company - Lilly Receives Fourth FDA Approval for ALIMTA(R) (pemetrexed for injection)” View full resource at newsroom.lilly.com
Most Recently Shared on July 6, 2009 at 2:56 pm By:
eyeonfda Pharma and Health Lawyer
ALIMTA First Chemotherapy Approved As Maintenance Therapy For Nonsquamous Non-Small Cell Lung Cancer - http://bit.ly/bN3Lz
Advertisement
